Dr. Joseph Delaney, research associate professor of epidemiology at the University of Washington School of Public Health, has received two grants from the National Institute on Drug Abuse (NIDA) to evaluate substance use trends among people living with human immunodeficiency virus (HIV) as a means to improve harm reduction efforts.
The first grant, a $3.8 million award, will be used to evaluate trends in opioid use among people living with HIV.
“Gathering data from Ohio, Kentucky and New England, places that the epidemic has hit hard, will help us better understand how the use of opioids changes from place to place and how it affects different populations,” Dr. Delaney said. “These findings could help identify recommendations for improved care.”
The second grant, for more than $400,000, is to evaluate how changes in marijuana legalization impact patterns of substance use. In particular, Dr. Delaney and his team are interested in whether legalization increases or decreases marijuana use by people living with HIV.Friday Letter Submission, Publish on August 09